Summit Therapeutics (SMMT) Tax Rate (2017 - 2020)
Summit Therapeutics' (SMMT) quarterly Tax Rate came in at 0.15% in Q4 2020, down 454.0% YoY from 0.04% in Q1 2020, and down 50.78% on a QoQ basis from 0.31% in Q3 2020.
Powered by 
Analysis
Summit Therapeutics (SMMT) Tax Rate (2017 - 2020) Analysis & Trends
Summit Therapeutics (SMMT) has 4 years of Tax Rate data on file, last reported at 0.15% in Q4 2020.
- Quarterly Tax Rate fell 454.0% year-over-year to 0.15% in Q4 2020, while the trailing twelve-month figure through Sep 2021 was 0.03% (down 275.0% YoY) and the FY2020 annual result came in at 0.4%, up 53.0% from the prior year.
- Tax Rate fell to 0.15% in Q4 2020, from 0.31% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 63.0% in Q4 2017 to a low of 1.78% in Q1 2018.
- A 4-year average of 11.41% and a median of 7.03% in 2019 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2018 — Tax Rate tumbled 4945 bps — and 2019, when it jumped 1526 bps.
- Tracing SMMT's Tax Rate over 4 years: stood at 63.0% in 2017, then tumbled by 78 bps to 13.55% in 2018, then sank by 65 bps to 4.69% in 2019, then tumbled by 97 bps to 0.15% in 2020.
- The last three Tax Rate figures came in at 0.15% (Q4 2020), 0.31% (Q3 2020), and 1.23% (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -16.71% |
| 10 | Summit Therapeutics | 13.47 Bn | 12.78 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 0.15% |
| Sep 30, 2020 | 0.31% |
| Jun 30, 2020 | 1.23% |
| Mar 31, 2020 | -0.72% |
| Dec 31, 2019 | 13.31% |
| Oct 31, 2019 | 9.37% |
| Sep 30, 2019 | -1.77% |
| Jul 31, 2019 | 17.07% |
| Mar 31, 2019 | 13.47% |
| Oct 31, 2018 | 13.55% |
| Jul 31, 2018 | 1.81% |
| Apr 30, 2018 | 13.94% |
| Jan 31, 2018 | -1.78% |
| Oct 31, 2017 | 63.00% |
| Jul 31, 2017 | 28.11% |
| Apr 30, 2017 | 20.17% |